Ocera Presents Three Posters and an Oral Presentation on OCR-002 at the AASLD Liver Meeting®
Oct 20, 2017 11:30 am UTC| Business
REDWOOD CITY, Calif. and RESEARCH TRIANGLE PARK, N.C., Oct. 20, 2017 -- Ocera Therapeutics, Inc. (NASDAQ:OCRX), today announced that clinical study findings of OCR-002 (ornithine phenylacetate) in development for the...
Beneficial Bancorp, Inc. Announces Third Quarter Results and Cash Dividend to Shareholders
Oct 20, 2017 11:30 am UTC| Business
PHILADELPHIA, Oct. 20, 2017 -- Beneficial Bancorp, Inc. (“Beneficial”) (NASDAQ:BNCL), the parent company of Beneficial Bank (the “Bank”), today announced its financial results for the three and nine months ended...
iPass to Report Third Quarter 2017 Financial Results on November 1
Oct 20, 2017 11:05 am UTC| Business
REDWOOD SHORES, Calif., Oct. 20, 2017 -- iPass Inc. (NASDAQ:IPAS), a leading provider of global mobile connectivity, announced it plans to release its financial results for the third quarter of 2017 on Wednesday,...
Oct 20, 2017 11:01 am UTC| Business
XI’AN, China, Oct. 20, 2017 -- China Green Agriculture, Inc. (NYSE:CGA) (“China Green Agriculture” or the “Company”), a company which mainly produces and distributes humic acid-based compound fertilizers, varieties of...
GasLog Partners LP Announces Closing Of Solaris Acquisition From GasLog Ltd.
Oct 20, 2017 11:01 am UTC| Business
MONACO - October 20, 2017 - GasLog Partners LP (NYSE:GLOP) ("GasLog Partners" or the "Partnership") and GasLog Ltd. (NYSE:GLOG) ("GasLog") announced today the closing of the Partnership's acquisition from GasLog of 100% of...
VBL Therapeutics Announces Orphan Drug Designation for VB-111 in Europe
Oct 20, 2017 11:00 am UTC| Business
New EMA orphan approval for Ovarian Cancer complements previously granted VB-111 orphan status for Glioblastoma in the US and Europe TEL AVIV, Israel, Oct. 20, 2017 -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage...
Emerald Health Pharmaceuticals Granted FDA Orphan Drug Designation for Systemic Scleroderma
Oct 20, 2017 11:00 am UTC| Business
SAN DIEGO, Oct. 20, 2017 -- Emerald Health Pharmaceuticals Inc. (EHP), which is developing medications based on cannabinoid science, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan...